Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ARYL AND HETEROARYL COMPOUNDS AND METHODS TO MODULATE COAGULATION
Document Type and Number:
WIPO Patent Application WO2004014844
Kind Code:
A3
Abstract:
This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as antagonists, or more preferably, partial antagonist of factor IX and thus, may be used to inhibit the intrinsic pathway of blood coagulation. The compounds are useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway utilizing factor IX. Such diseases or disease states include stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures, long periods of confinement, and acquired or inherited pro-coagulant states.

Inventors:
MJALLI ADNAN M M (US)
ANDREWS ROB (US)
GUO XIAO-CHUAN (US)
CHRISTEN DANIEL PETER (US)
GOHIMMUKKULA DEVI REDDY (US)
HUANG GUOXIANG (US)
ROTHLEIN ROBERT (US)
TYAGI SAMEER (US)
YARAMASU TRIPURA (US)
BEHME CHRISTOPHER (US)
Application Number:
PCT/US2003/025045
Publication Date:
April 28, 2005
Filing Date:
August 08, 2003
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TRANSTECH PHARMA INC (US)
MJALLI ADNAN M M (US)
ANDREWS ROB (US)
GUO XIAO-CHUAN (US)
CHRISTEN DANIEL PETER (US)
GOHIMMUKKULA DEVI REDDY (US)
HUANG GUOXIANG (US)
ROTHLEIN ROBERT (US)
TYAGI SAMEER (US)
YARAMASU TRIPURA (US)
BEHME CHRISTOPHER (US)
International Classes:
A61K31/166; A61K31/167; A61K31/198; A61K31/341; A61K31/343; A61K31/381; A61K31/402; A61K31/4025; A61K31/4155; A61K31/4164; A61K31/421; A61K31/422; A61K31/4245; A61K31/433; A61K31/44; A61K31/4409; A61K31/4418; A61K31/4453; A61K31/4465; A61K31/472; A61K31/501; A61K31/506; A61K31/517; A61K31/5377; A61K31/55; A61K31/609; A61K31/625; A61K31/63; A61P7/02; A61P9/06; A61P9/10; A61P9/14; A61P13/12; A61P15/06; A61P29/00; A61P37/00; A61P41/00; A61P43/00; C07C233/29; C07C233/87; C07C235/42; C07C235/52; C07C235/60; C07C235/66; C07C237/20; C07C237/36; C07C237/42; C07C237/44; C07C255/58; C07C255/60; C07C257/18; C07C271/20; C07C271/44; C07C311/18; C07C311/19; C07C311/29; C07C311/44; C07C317/14; C07C317/28; C07C317/36; C07C317/46; C07C323/36; C07D207/09; C07D207/267; C07D207/27; C07D207/48; C07D211/14; C07D211/26; C07D213/30; C07D213/38; C07D213/55; C07D213/56; C07D213/70; C07D213/71; C07D213/74; C07D213/75; C07D213/81; C07D213/82; C07D215/36; C07D217/02; C07D217/04; C07D217/16; C07D217/22; C07D217/26; C07D231/12; C07D231/14; C07D231/18; C07D233/84; C07D239/94; C07D249/08; C07D261/10; C07D263/32; C07D271/10; C07D277/20; C07D277/44; C07D277/46; C07D277/54; C07D285/06; C07D285/08; C07D295/08; C07D295/092; C07D295/14; C07D295/155; C07D307/52; C07D307/66; C07D307/79; C07D307/85; C07D317/60; C07D317/66; C07D333/20; C07D333/24; C07D333/38; C07D333/70; C07D401/04; C07D403/04; C07D409/04; C07D409/06; C07D413/04; C07D207/26; (IPC1-7): C07C233/29; C07C233/87; C07C235/42; C07C235/52; C07C235/60; C07C235/66; C07D217/16; C07D217/22; A61K31/33; A61K31/198; A61P7/02
Domestic Patent References:
WO2002018320A22002-03-07
WO1999036393A11999-07-22
WO1999026923A11999-06-03
WO2001021584A12001-03-29
WO1995012611A11995-05-11
Foreign References:
GB2354440A2001-03-28
GB1501541A1978-02-15
Other References:
H.S. KNOWLES ET AL, TETRAHEDRON, vol. 57, no. 38, 2001, pages 8115 - 8124, XP004319720
M.J. O'DONNELL ET AL, TETRAHEDRON, vol. 55, no. 20, 1999, pages 6347 - 6362, XP004165578
G.M. CASTANEDO ET AL, BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 12, no. 20, 2002, pages 2913 - 2917, XP002250476
DATABASE CAPLUS CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002319820, retrieved from STN Database accession no. 1973:504834
P.D. GREENSPAN ET AL, BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 7, no. 7, 1997, pages 949 - 954, XP004136162
Download PDF: